BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1989 related articles for article (PubMed ID: 19435819)

  • 21. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
    Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
    Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis.
    Ross CW; Ouillette PD; Saddler CM; Shedden KA; Malek SN
    Clin Cancer Res; 2007 Aug; 13(16):4777-85. PubMed ID: 17699855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
    Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
    Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 1q44 deletion, paternal UPD of chromosome 2 and a deletion due to a complex translocation detected in children with abnormal phenotypes using new SNP array technology.
    Talseth-Palmer BA; Bowden NA; Meldrum C; Nicholl J; Thompson E; Friend K; Liebelt J; Bratkovic D; Haan E; Yu S; Scott RJ
    Cytogenet Genome Res; 2009; 124(1):94-101. PubMed ID: 19372674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA copy number variation and gene expression analyses reveal the implication of specific oncogenes and genes in GBM.
    Margareto J; Leis O; Larrarte E; Pomposo IC; Garibi JM; Lafuente JV
    Cancer Invest; 2009 Jun; 27(5):541-8. PubMed ID: 19219654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy.
    Nowak D; Nolte F; Mossner M; Nowak V; Baldus CD; Hopfer O; Noll S; Thiel E; Wagner F; Hofmann WK
    Exp Hematol; 2009 Feb; 37(2):215-224. PubMed ID: 19135900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
    Lake SL; Coupland SE; Taktak AF; Damato BE
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
    Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations.
    Arjona D; Bello MJ; Alonso ME; Aminoso C; Isla A; De Campos JM; Sarasa JL; Gutierrez M; Villalobo A; Rey JA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):384-94. PubMed ID: 16008822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays.
    Suzuki M; Kato M; Yuyan C; Takita J; Sanada M; Nannya Y; Yamamoto G; Takahashi A; Ikeda H; Kuwano H; Ogawa S; Hayashi Y
    Cancer Sci; 2008 Mar; 99(3):564-70. PubMed ID: 18271875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
    Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
    Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p53 and p21 in primary glioblastomas.
    Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
    Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
    Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
    Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors.
    Yin D; Xie D; Hofmann WK; Miller CW; Black KL; Koeffler HP
    Oncogene; 2002 Nov; 21(54):8372-8. PubMed ID: 12447702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 100.